Company Information for OLD CONVERGENCE PHARMACEUTICALS LIMITED
BUILDING 5 FOUNDATION PARK, ROXBOROUGH WAY, MAIDENHEAD, BERKSHIRE, SL6 3UD,
|
Company Registration Number
07289568
Private Limited Company
Active |
Company Name | ||||
---|---|---|---|---|
OLD CONVERGENCE PHARMACEUTICALS LIMITED | ||||
Legal Registered Office | ||||
BUILDING 5 FOUNDATION PARK ROXBOROUGH WAY MAIDENHEAD BERKSHIRE SL6 3UD Other companies in WC1V | ||||
Previous Names | ||||
|
Company Number | 07289568 | |
---|---|---|
Company ID Number | 07289568 | |
Date formed | 2010-06-18 | |
Country | ENGLAND | |
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 31/12/2023 | |
Account next due | 30/09/2025 | |
Latest return | 18/06/2016 | |
Return next due | 16/07/2017 | |
Type of accounts | DORMANT |
Last Datalog update: | 2024-07-05 17:29:10 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
STEVEN JOHN GREEN |
||
TREVOR ANTHONY MILL |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
SIMON NICHOLAS TATE |
Director | ||
DAVID JOHN WATSON |
Director | ||
BRENDA ELIZABETH REYNOLDS |
Company Secretary | ||
CLIVE JAMES DIX |
Director | ||
BRENDA ELIZABETH REYNOLDS |
Director | ||
CATHERINE ELIZABETH BINGHAM |
Director | ||
ALLAN PATRICK MARCHINGTON |
Director | ||
LIAM THOMAS RATCLIFFE |
Director | ||
CHRISTOPHER HOLLOWOOD |
Director | ||
BRENDA ELIZABETH REYNOLDS |
Company Secretary | ||
BRENDA ELIZABETH REYNOLDS |
Director | ||
SIMON TATE |
Company Secretary | ||
OLSWANG COSEC LIMITED |
Company Secretary | ||
CHRISTOPHER ALAN MACKIE |
Director | ||
OLSWANG DIRECTORS 1 LIMITED |
Director | ||
OLSWANG DIRECTORS 2 LIMITED |
Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED | Director | 2018-04-12 | CURRENT | 2011-04-07 | Active | |
CONVERGENCE PHARMACEUTICALS LIMITED | Director | 2015-01-06 | CURRENT | 2015-01-06 | Active | |
SILVER ACQUISITION CO LIMITED | Director | 2014-12-19 | CURRENT | 2014-12-19 | Active | |
BIOGEN IDEC RESEARCH LIMITED | Director | 2011-08-11 | CURRENT | 2011-04-01 | Active | |
CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED | Director | 2015-02-11 | CURRENT | 2011-04-07 | Active | |
CONVERGENCE PHARMACEUTICALS LIMITED | Director | 2015-01-06 | CURRENT | 2015-01-06 | Active | |
SILVER ACQUISITION CO LIMITED | Director | 2014-12-19 | CURRENT | 2014-12-19 | Active | |
BIOGEN IDEC LIMITED | Director | 2012-04-16 | CURRENT | 1980-05-19 | Active | |
BIOGEN IDEC RESEARCH LIMITED | Director | 2011-09-15 | CURRENT | 2011-04-01 | Active |
Date | Document Type | Document Description |
---|---|---|
Change of details for Convergence Pharmaceuticals Holdings Limited as a person with significant control on 2024-06-16 | ||
CONFIRMATION STATEMENT MADE ON 18/06/24, WITH NO UPDATES | ||
ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/23 | ||
ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/22 | ||
REGISTERED OFFICE CHANGED ON 10/08/23 FROM 70 Norden Road Maidenhead Berkshire SL6 4AY | ||
Director's details changed for Director Kylie Michele Bromley on 2023-06-16 | ||
CONFIRMATION STATEMENT MADE ON 18/06/23, WITH NO UPDATES | ||
APPOINTMENT TERMINATED, DIRECTOR LORI ELIZABETH MOCHAN | ||
DIRECTOR APPOINTED GERONIMO MARTINEZ | ||
FULL ACCOUNTS MADE UP TO 31/12/21 | ||
AA | FULL ACCOUNTS MADE UP TO 31/12/21 | |
AP01 | DIRECTOR APPOINTED DIRECTOR KYLIE MICHELE BROMLEY | |
CS01 | CONFIRMATION STATEMENT MADE ON 18/06/22, WITH NO UPDATES | |
APPOINTMENT TERMINATED, DIRECTOR ALEXANDRA ISABELLA HANDRICH | ||
TM01 | APPOINTMENT TERMINATED, DIRECTOR ALEXANDRA ISABELLA HANDRICH | |
AA | FULL ACCOUNTS MADE UP TO 31/12/20 | |
CS01 | CONFIRMATION STATEMENT MADE ON 18/06/21, WITH NO UPDATES | |
AA | FULL ACCOUNTS MADE UP TO 31/12/19 | |
CS01 | CONFIRMATION STATEMENT MADE ON 18/06/20, WITH UPDATES | |
AP01 | DIRECTOR APPOINTED LORI ELIZABETH MOCHAN | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR STEVEN JOHN GREEN | |
SH19 | Statement of capital on 2020-04-22 GBP 1 | |
RES13 | Resolutions passed:
| |
SH20 | Statement by Directors | |
CAP-SS | Solvency Statement dated 08/04/20 | |
CH01 | Director's details changed for Ms Helen Elizabeth Hanby on 2020-02-21 | |
AP01 | DIRECTOR APPOINTED MS HELEN ELIZABETH HANBY | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR TREVOR ANTHONY MILL | |
AA | FULL ACCOUNTS MADE UP TO 31/12/18 | |
CS01 | CONFIRMATION STATEMENT MADE ON 18/06/19, WITH NO UPDATES | |
AA | FULL ACCOUNTS MADE UP TO 31/12/17 | |
CS01 | CONFIRMATION STATEMENT MADE ON 18/06/18, WITH NO UPDATES | |
AP01 | DIRECTOR APPOINTED STEVEN JOHN GREEN | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR SIMON TATE | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DAVID WATSON | |
AA | FULL ACCOUNTS MADE UP TO 31/12/16 | |
CS01 | CONFIRMATION STATEMENT MADE ON 18/06/17, WITH NO UPDATES | |
PSC02 | Notification of Convergence Pharmaceuticals Holdings Limited as a person with significant control on 2016-04-06 | |
AD03 | Registers moved to registered inspection location of 7 Albemarle Street London W1S 4HQ | |
AD02 | Register inspection address changed to 7 Albemarle Street London W1S 4HQ | |
AA | FULL ACCOUNTS MADE UP TO 31/12/15 | |
LATEST SOC | 08/07/16 STATEMENT OF CAPITAL;GBP 17318.512 | |
AR01 | 18/06/16 ANNUAL RETURN FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 31/12/14 | |
LATEST SOC | 13/07/15 STATEMENT OF CAPITAL;GBP 17318.512 | |
AR01 | 18/06/15 ANNUAL RETURN FULL LIST | |
RES15 | CHANGE OF NAME 30/03/2015 | |
CERTNM | Company name changed convergence pharmaceuticals LIMITED\certificate issued on 24/04/15 | |
CONNOT | NOTICE OF CHANGE OF NAME NM01 - RESOLUTION | |
AA01 | Previous accounting period shortened from 30/09/15 TO 31/12/14 | |
AP01 | DIRECTOR APPOINTED MR DAVID WATSON | |
AP01 | DIRECTOR APPOINTED MR TREVOR ANTHONY MILL | |
RES13 | Resolutions passed:<ul><li>Section 175 of ca 2006 11/02/2015</ul> | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CLIVE DIX | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR BRENDA REYNOLDS | |
TM02 | Termination of appointment of Brenda Elizabeth Reynolds on 2015-02-11 | |
AA | FULL ACCOUNTS MADE UP TO 30/09/14 | |
AD01 | REGISTERED OFFICE CHANGED ON 12/02/2015 FROM 90 HIGH HOLBORN LONDON WC1V 6XX | |
LATEST SOC | 08/07/14 STATEMENT OF CAPITAL;GBP 17318.512 | |
AR01 | 18/06/14 FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 30/09/13 | |
AP01 | DIRECTOR APPOINTED MS BRENDA ELIZABETH REYNOLDS | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR LIAM RATCLIFFE | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ALLAN MARCHINGTON | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CATHERINE BINGHAM | |
AR01 | 18/06/13 FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 30/09/12 | |
AP01 | DIRECTOR APPOINTED ALLAN PATRICK MARCHINGTON | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CHRIS HOLLOWOOD | |
AR01 | 18/06/12 FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 30/09/11 | |
RES01 | ADOPT ARTICLES 03/10/2011 | |
RES13 | CONFLICT OF INTEREST 03/10/2011 | |
SH10 | NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES | |
SH01 | 03/10/11 STATEMENT OF CAPITAL GBP 17318.510 | |
AR01 | 18/06/11 FULL LIST | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / CLIVE JAMES DIX / 18/06/2011 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR BRENDA REYNOLDS | |
AP03 | SECRETARY APPOINTED MRS BRENDA ELIZABETH REYNOLDS | |
AP01 | DIRECTOR APPOINTED MRS CATHERINE ELIZABETH BINGHAM | |
AP01 | DIRECTOR APPOINTED MR CHRIS HOLLOWOOD | |
AP01 | DIRECTOR APPOINTED MR LIAM RATCLIFFE | |
TM02 | APPOINTMENT TERMINATED, SECRETARY BRENDA REYNOLDS | |
SH02 | SUB-DIVISION 04/10/10 | |
SH10 | NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES | |
SH08 | NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES | |
SH01 | 04/10/10 STATEMENT OF CAPITAL GBP 13585.02 | |
RES01 | ADOPT ARTICLES 04/10/2010 | |
RES12 | VARYING SHARE RIGHTS AND NAMES | |
AA01 | CURREXT FROM 30/06/2011 TO 30/09/2011 | |
TM02 | APPOINTMENT TERMINATED, SECRETARY SIMON TATE | |
AP03 | SECRETARY APPOINTED BRENDA ELIZABETH REYNOLDS | |
AP01 | DIRECTOR APPOINTED BRENDA ELIZABETH REYNOLDS | |
AP01 | DIRECTOR APPOINTED CLIVE JAMES DIX | |
RES15 | CHANGE OF NAME 15/07/2010 | |
CERTNM | COMPANY NAME CHANGED NEWINCCO 1020 LIMITED CERTIFICATE ISSUED ON 19/07/10 | |
CONNOT | NOTICE OF CHANGE OF NAME NM01 - RESOLUTION | |
NM06 | REQUEST TO SEEK COMMENTS OF GOVERNMENT DEPARTMENT OR OTHER SPECIFIED BODY ON CHANGE OF NAME | |
AP01 | DIRECTOR APPOINTED SIMON NICHOLAS TATE | |
AP03 | SECRETARY APPOINTED SIMON TATE | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CHRISTOPHER MACKIE | |
TM02 | APPOINTMENT TERMINATED, SECRETARY OLSWANG COSEC LIMITED | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR OLSWANG DIRECTORS 2 LIMITED | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR OLSWANG DIRECTORS 1 LIMITED | |
NEWINC | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
Total # Mortgages/Charges | 0 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
Average | Max | |
MortgagesNumMortCharges | 0.33 | 8 |
MortgagesNumMortOutstanding | 0.17 | 8 |
MortgagesNumMortPartSatisfied | 0.00 | 1 |
MortgagesNumMortSatisfied | 0.16 | 8 |
This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology
|
|
|
|
|
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on OLD CONVERGENCE PHARMACEUTICALS LIMITED
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as OLD CONVERGENCE PHARMACEUTICALS LIMITED are:
Category | Award/Grant | |
---|---|---|
Discovery of P2Y14 antagonists for the treatment of osteoarthritic pain : Feasibility Study | 2014-04-01 | £ 2,400,000 |
How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |